Collegium Pharmaceutical, Inc. Financials

Market Capitalization $1.05 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	13.93
Forward PE	4.89
Price to Sales TTM	$1.75
Price to Book MRQ	$4.48
Enterprise to Revenue	2.97
Enterprise to EBITDA	4.87

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	14.78%
Operating Margin	35.17%
Return on Assets TTM	9.68%
Return on Equity TTM	42.89%

Income Statement

Revenue TTM	$599,244,992
Revenue per Share TTM	$18.54
Quarterly Revenue Growth	16.50%
Gross Profit TTM	$519,334,016
EBITDA	$358,050,000
Net Income to Common TTM	$88,594,000
Diluted EPS TTM	$2.34
Quarterly Earnings Growth YoY	-54.80%

Balance Sheet

Total Cash MRQ	$144,956,992
Total Cash per Share MRQ	$4.50
Total Debt MRQ	$
Total Debt to Equity MRQ	373.23
Current Ratio MRQ	0.97
Book Value per Share MRQ	$7.27

Cash Flow

Operating Cash Flow TTM	$193,674,000
Levered Free Cash Flow TTM	$324,093,120

COLL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	32,250,200
Float Shares	29,525,414
Avg 10 Volume	415,200
Avg 30 Volume	None
Shares Short	5,983,188
Short Ratio	12.87
Short % of Shares	23.00%
% Held by Insiders	1.64%
% Held by Institutions	120.05%

Stock Price Summary

Beta	0.95
Fifty Two Week Low	$28.39
Fifty Two Week High	$42.29
Fifty Two Week Change	-3.99%
Day 50 MA	$30.71
Day 200 MA	$34.14

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date